US Patent Issued to SPECIFIC BIOLOGICS on May 13 for "Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing" (Canadian Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,467, issued on May 13, was assigned to SPECIFIC BIOLOGICS INC. (Ontario, Canada).

"Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing" was invented by David R. Edgell (London, Canada), Thomas A. McMurrough (London, Canada), Brent E. Stead (Toronto) and Odisho K. Israel (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods to edit genes by administering a chimeric nuclease to a cell or organism without the use of a viral vector."

The patent was filed on June 22, 2022, under Application No. 17/846,771.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?...